<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092777/" ref="ordinalpos=3024&amp;ncbi_uid=2952927&amp;link_uid=PMC3092777" image-link="/pmc/articles/PMC3092777/figure/pone-0019787-g004/" class="imagepopup">Figure 4. Inhibition of the BMP4 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> abolished the pro-cardiogenic effects of apoA-I gene transfer..  From: Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells. </a></div><br /><div class="p4l_captionBody">The BMP4 signaling pathway was inhibited by the application of noggin (1 µ/ml) to the apoA-I- transduced ESCs upon plating. (A) The phosphorylation status of the differentiating cells was evaluated 24 hr after noggin treatment. (B) The appearance of beating clusters during the 8-day period of differentiation. (C) The percentage of troponin-T positive cells as determined by flow cytometry analysis. Data shown as mean ± SEM from 3 independent experiments, # p&lt;0.05 comparing to the LV-apoA-I group; *p&lt;0.05 and ** p&lt;0.005 comparing to the LV-GFP group.</div></div>